Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-9845.2%EBITDA Margin
VS
Market
Sector
Industry
History
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -49.23M | -9845.2% | $ 500K |
| 3/31/2025 | $ -46.22M | 0% | $ 0 |
| 12/31/2024 | $ -42.44M | 0% | $ 0 |
| 6/30/2024 | $ -35.67M | -3272.87% | $ 1.09M |
| 12/31/2023 | $ -27.34M | -273.36% | $ 10M |
| 6/30/2023 | $ -30.55M | -342.9% | $ 8.91M |
| 12/31/2022 | $ -40.01M | 0% | $ 0 |
| 6/30/2022 | $ -14.8M | 0% | $ 0 |
| 12/31/2021 | $ 23.63M | 51.85% | $ 45.58M |
| 6/30/2021 | $ -147.33M | -323.23% | $ 45.58M |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average EBITDA % has been -2334.29%.
- The median EBITDA % for MEREO BIOPHARMA GROUP PLC during this period was -333.06%
- MEREO BIOPHARMA GROUP PLC reached its highest EBITDA % over the past 5 years at 51.85%.
- The lowest EBITDA % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -9845.2%
MEREO BIOPHARMA GROUP PLC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for MEREO BIOPHARMA GROUP PLC is calculated as follows: EBITDA [ $ -198.09M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] MREO - EBITDA Margin, Last 5 years
-9845.2%
Minimum
Jun 30, 2025
51.85%
Maximum
Dec 31, 2021
-2334.29%
Average
-333.06%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.15% |
| median | 14.67% |
| std | 26.84% |